Given that hepatocytes are a site of action/replication for malaria, an understanding of the potential liver exposures of proguanil and cycloguanil in subjects lacking OCT1 function is relevant as these may play a role in the pharmacodynamics, as discussed previously (Matthaei et al., 2019). Here, SLC22A1 is linked to malaria.